Arns, W., & Huppertz, A. (2017). Pharmacokinetics and clinical outcomes of generic tacrolimus (Hexal) versus branded tacrolimus in de novo kidney transplant patients: A multicenter, randomized trial. Transplantation, 101(11), . https://doi.org/10.1097/TP.0000000000001843
Chicago-Zitierstil (17. Ausg.)Arns, Wolfgang, und Andrea Huppertz. "Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial." Transplantation 101, no. 11 (2017). https://doi.org/10.1097/TP.0000000000001843.
MLA-Zitierstil (9. Ausg.)Arns, Wolfgang, und Andrea Huppertz. "Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial." Transplantation, vol. 101, no. 11, 2017, https://doi.org/10.1097/TP.0000000000001843.